SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, is expanding its collaboration with Roche in cellular therapy. Under the terms, SQZ and Roche will jointly develop and commercialize certain products based on antigen presenting cells (APCs) created by the SQZ platform for the treatment of oncology indications. “We believe that…